Literature DB >> 26228668

Lipid phenotypes at the extremes of high-density lipoprotein cholesterol: The very large database of lipids-9.

Renato Quispe1, Mohammed Al-Hijji2, Kristopher J Swiger2, Seth S Martin2, Mohamed B Elshazly3, Michael J Blaha2, Parag H Joshi2, Roger S Blumenthal2, Allan D Sniderman4, Peter P Toth5, Steven R Jones2.   

Abstract

BACKGROUND: Low serum levels of high-density lipoprotein cholesterol (HDL-C) are an important risk factor for atherosclerotic disease. To date, therapeutically raising HDL-C has not been shown to impact risk for cardiovascular events.
OBJECTIVE: We aim to characterize lipid parameters at the extremes of HDL-C.
METHODS: We examined cholesterol profiles from 1,350,908 US adults and children from the Very Large Database of Lipids who were clinically referred for advanced lipoprotein testing from 2009 to 2011. We categorized patients into HDL-C percentile categories (<0.1th, 0.1th-<1st, 1st-5th, 25th-75th, 95th-99th, >99th-99.9th, and >99.9th). Within these groups, we examined HDL-C subclasses, low-density lipoprotein cholesterol (LDL-C), LDL and very-low density lipoprotein densities, non-HDL-C, triglycerides (TG), very-low density lipoprotein cholesterol, and remnant lipoprotein cholesterol (RLP-C), as well as prevalence of Fredrickson-Levy dyslipidemias.
RESULTS: Extremely low HDL-C percentiles were associated with increased LDL density, TG, and especially RLP-C. Very high HDL-C levels (≥ 92 mg/dL) showed increasing HDL2-C/HDL3-C ratio and very low levels of RLP-C and triglyceride-rich lipoproteins. Type IV dyslipidemia had the highest prevalence among classical dyslipidemia and was the most frequent at extremely low HDL-C percentiles.
CONCLUSIONS: These findings demonstrate a high prevalence of elevated triglyceride-rich lipoprotein levels and increased LDL density in patients with extremely low HDL-C levels. The relative contributions of these various changes in lipid profiles of patients with low HDL-C to cardiovascular risk need to be further scrutinized to more fully establish if low HDL-C is truly an independent risk factor for coronary heart disease or simply reflects detrimental shifts in the levels of atherogenic lipoproteins.
Copyright © 2015 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular diseases; Dyslipidemia; High-density lipoprotein cholesterol; Lipids; Prevention

Mesh:

Substances:

Year:  2015        PMID: 26228668     DOI: 10.1016/j.jacl.2015.05.005

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  3 in total

1.  Associations between cardiovascular disease, cancer, and very low high-density lipoprotein cholesterol in the REasons for Geographical and Racial Differences in Stroke (REGARDS) study.

Authors:  Peter Penson; D Leann Long; George Howard; Virginia J Howard; Steven R Jones; Seth S Martin; Dimitri P Mikhailidis; Paul Muntner; Manfredi Rizzo; Daniel J Rader; Monika M Safford; Amirhossein Sahebkar; Peter P Toth; Maciej Banach
Journal:  Cardiovasc Res       Date:  2019-01-01       Impact factor: 10.787

2.  Impact of variants in CETP and apo AI genes on serum HDL cholesterol levels in men and women from the Polish population.

Authors:  Marta Włodarczyk; Małgorzata Wrzosek; Grażyna Nowicka; Beata Jabłonowska-Lietz
Journal:  Arch Med Sci       Date:  2016-06-27       Impact factor: 3.318

3.  Characterization of lipoprotein profiles in patients with hypertriglyceridemic Fredrickson-Levy and Lees dyslipidemia phenotypes: the Very Large Database of Lipids Studies 6 and 7.

Authors:  Renato Quispe; Aditya D Hendrani; Behnoud Baradaran-Noveiry; Seth S Martin; Emily Brown; Krishnaji R Kulkarni; Maciej Banach; Peter P Toth; Eliot A Brinton; Steven R Jones; Parag H Joshi
Journal:  Arch Med Sci       Date:  2019-08-22       Impact factor: 3.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.